Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03781739 · ClinicalTrials.gov registry record · Phase 1
MANP in Hypertension and Metabolic Syndrome
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT03781739: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT03781739 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03781739, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
Evaluate the cardiovascular and metabolic properties of MANP in subjects with HTN and MS according to rs5068 genotypes
Interventions
- DRUG MANP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2017-08-18 |
| Est. Completion | 2019-12-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03781739
The ClinicalTrials.gov registry entry for NCT03781739 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MANP is the first listed.
NCT03781739 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03781739 about?
NCT03781739 is a clinical study titled "MANP in Hypertension and Metabolic Syndrome". Evaluate the cardiovascular and metabolic properties of MANP in subjects with HTN and MS according to rs5068 genotypes
What is the current status of trial NCT03781739?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2017-08-18. Estimated completion is 2019-12-10.
What interventions are being tested in trial NCT03781739?
The interventions under investigation include: MANP (DRUG).
Who is sponsoring clinical trial NCT03781739?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.